NEUROGENE INC (NGNE) Stock Analyst Ratings
USA - NASDAQ:NGNE - US64135M1053 - Common Stock
26.66 USD
-1.06 (-3.82%)
26.66 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to NGNE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 53.81. This target is 101.82% above the current price.
NGNE was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NGNE.
In the previous month the buy percentage consensus was at a similar level.
NGNE was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-17 | Craig-Hallum | Initiate | Buy |
| 2025-06-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-05-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-05-16 | Baird | Downgrade | Outperform -> Neutral |
| 2025-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-14 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-11-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-12 | Stifel | Maintains | Buy -> Buy |
| 2024-11-12 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-27 | BMO Capital | Initiate | Outperform |
| 2024-06-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-11 | Baird | Initiate | Outperform |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-29 | Leerink Partners | Initiate | Outperform |
| 2024-03-21 | William Blair | Initiate | Outperform |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
NEUROGENE INC / NGNE FAQ
What is the price target for NGNE stock?
13 analysts have analysed NGNE and the average price target is 53.81 USD. This implies a price increase of 101.82% is expected in the next year compared to the current price of 26.66.
How do analysts rate NEUROGENE INC (NGNE)?
The consensus rating for NEUROGENE INC (NGNE) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for NGNE stock?
The number of analysts covering NEUROGENE INC (NGNE) is 13.